Literature DB >> 32425370

Alternative Strategies in Thalassemia: Focus on Thalidomide.

R Naithani1, P Jeyaraman1, M Mahapatra1.   

Abstract

Entities:  

Year:  2020        PMID： 32425370      PMCID： PMC7229089          DOI： 10.1007/s12288-020-01285-w

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  8 in total

1.  Thalidomide has a significant effect in patients with thalassemia intermedia.

Authors:  YunShuan Li; Quan Ren; Yali Zhou; Pingping Li; Wanhua Lin; Xiaolin Yin
Journal:  Hematology       Date:  2017-07-18       Impact factor: 2.269

Review 2.  Fetal Hemoglobin Induction by Epigenetic Drugs.

Authors:  Donald Lavelle; James Douglas Engel; Yogen Saunthararajah
Journal:  Semin Hematol       Date:  2018-04-22       Impact factor: 3.851

3.  Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy.

Authors:  Nicoletta Masera; Luisa Tavecchia; Marietta Capra; Giovanni Cazzaniga; Chiara Vimercati; Lorena Pozzi; Andrea Biondi; Giuseppe Masera
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

4.  Dramatic erythroid response to low-dose thalidomide in two patients with transfusion independent thalassemia and severe post-transfusional alloimmune hemolysis.

Authors:  Claudio Fozza; Simonetta Pardini; Domenica Barbara Giannico; Clara Targhetta; Anna Angela Di Tucci; Paolo Dessalvi; Emanuele Angelucci; Fausto Dore
Journal:  Am J Hematol       Date:  2015-07       Impact factor: 10.047

5.  Safety and effectiveness of thalidomide and hydroxyurea combination in β-thalassaemia intermedia and major: a retrospective pilot study.

Authors:  Sandip Shah; Radhika Sheth; Kamlesh Shah; Kinnari Patel
Journal:  Br J Haematol       Date:  2019-11-11       Impact factor: 6.998

Review 6.  A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?

Authors:  Maria Domenica Cappellini; John B Porter; Vip Viprakasit; Ali T Taher
Journal:  Blood Rev       Date:  2018-02-12       Impact factor: 8.250

7.  Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis.

Authors:  Wulin Aerbajinai; Jianqiong Zhu; Zhigang Gao; Kyung Chin; Griffin P Rodgers
Journal:  Blood       Date:  2007-07-09       Impact factor: 22.113

8.  Spectrum of Hemoglobinopathies: A New Revelation in a Tertiary Care Hospital of Odisha.

Authors:  Gopal Krushna Ray; Rabindra Kumar Jena
Journal:  Indian J Hematol Blood Transfus       Date:  2018-12-01       Impact factor: 0.900
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.